Diagnostic criteria for the neuropathological assessment of Alzheimer's disease: Current status and major issues

H. M. Wisniewski, Wayne P Silverman

Research output: Contribution to journalArticle

Abstract

A Consensus Conference focusing on Alzheimer's disease (AD) took place in November 1996 to recommend uniform evaluation procedures and diagnostic criteria, co-sponsored by the National Institute on Aging and the Reagan Institute of the Alzheimer's Association. In conjunction with this conference, we reviewed diagnostic practices in current use, together with various neuropathological criteria proposed since 1985. Difficulties were identified in developing 'gold standard' criteria for diagnosis and case classification of AD based upon the current state of knowledge. Working criteria for use within research contexts were proposed that acknowledged the realities of scientific limitations by inclusion of a broad and heterogeneous category of 'uncertain' cases. (Eventually, methods will be developed for identifying these cases as preclinical AD, dementia due to multiple causes or non-AD, but this is not now possible.) Within applied contexts, the use of CERAD guidelines was supported. Finally, recommendations generated at the Consensus Conference were discussed, emphasizing the rapid pace of recent scientific advancement and the need for ongoing empirical reevaluation and modification of the Group's proposal.

Original languageEnglish (US)
JournalNeurobiology of Aging
Volume18
Issue number4 SUPPL.
DOIs
StatePublished - Jul 1997
Externally publishedYes

Fingerprint

Alzheimer Disease
Consensus
National Institute on Aging (U.S.)
Guidelines
Research

Keywords

  • β-Amyloid pathology
  • Alzheimer's disease
  • Diagnosis
  • Neurofibrillary pathology
  • Neuropathology

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

Diagnostic criteria for the neuropathological assessment of Alzheimer's disease : Current status and major issues. / Wisniewski, H. M.; Silverman, Wayne P.

In: Neurobiology of Aging, Vol. 18, No. 4 SUPPL., 07.1997.

Research output: Contribution to journalArticle

@article{5a30dd16c9ee48eab410bc8d8ebf31c0,
title = "Diagnostic criteria for the neuropathological assessment of Alzheimer's disease: Current status and major issues",
abstract = "A Consensus Conference focusing on Alzheimer's disease (AD) took place in November 1996 to recommend uniform evaluation procedures and diagnostic criteria, co-sponsored by the National Institute on Aging and the Reagan Institute of the Alzheimer's Association. In conjunction with this conference, we reviewed diagnostic practices in current use, together with various neuropathological criteria proposed since 1985. Difficulties were identified in developing 'gold standard' criteria for diagnosis and case classification of AD based upon the current state of knowledge. Working criteria for use within research contexts were proposed that acknowledged the realities of scientific limitations by inclusion of a broad and heterogeneous category of 'uncertain' cases. (Eventually, methods will be developed for identifying these cases as preclinical AD, dementia due to multiple causes or non-AD, but this is not now possible.) Within applied contexts, the use of CERAD guidelines was supported. Finally, recommendations generated at the Consensus Conference were discussed, emphasizing the rapid pace of recent scientific advancement and the need for ongoing empirical reevaluation and modification of the Group's proposal.",
keywords = "β-Amyloid pathology, Alzheimer's disease, Diagnosis, Neurofibrillary pathology, Neuropathology",
author = "Wisniewski, {H. M.} and Silverman, {Wayne P}",
year = "1997",
month = "7",
doi = "10.1016/S0197-4580(97)00068-7",
language = "English (US)",
volume = "18",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Diagnostic criteria for the neuropathological assessment of Alzheimer's disease

T2 - Current status and major issues

AU - Wisniewski, H. M.

AU - Silverman, Wayne P

PY - 1997/7

Y1 - 1997/7

N2 - A Consensus Conference focusing on Alzheimer's disease (AD) took place in November 1996 to recommend uniform evaluation procedures and diagnostic criteria, co-sponsored by the National Institute on Aging and the Reagan Institute of the Alzheimer's Association. In conjunction with this conference, we reviewed diagnostic practices in current use, together with various neuropathological criteria proposed since 1985. Difficulties were identified in developing 'gold standard' criteria for diagnosis and case classification of AD based upon the current state of knowledge. Working criteria for use within research contexts were proposed that acknowledged the realities of scientific limitations by inclusion of a broad and heterogeneous category of 'uncertain' cases. (Eventually, methods will be developed for identifying these cases as preclinical AD, dementia due to multiple causes or non-AD, but this is not now possible.) Within applied contexts, the use of CERAD guidelines was supported. Finally, recommendations generated at the Consensus Conference were discussed, emphasizing the rapid pace of recent scientific advancement and the need for ongoing empirical reevaluation and modification of the Group's proposal.

AB - A Consensus Conference focusing on Alzheimer's disease (AD) took place in November 1996 to recommend uniform evaluation procedures and diagnostic criteria, co-sponsored by the National Institute on Aging and the Reagan Institute of the Alzheimer's Association. In conjunction with this conference, we reviewed diagnostic practices in current use, together with various neuropathological criteria proposed since 1985. Difficulties were identified in developing 'gold standard' criteria for diagnosis and case classification of AD based upon the current state of knowledge. Working criteria for use within research contexts were proposed that acknowledged the realities of scientific limitations by inclusion of a broad and heterogeneous category of 'uncertain' cases. (Eventually, methods will be developed for identifying these cases as preclinical AD, dementia due to multiple causes or non-AD, but this is not now possible.) Within applied contexts, the use of CERAD guidelines was supported. Finally, recommendations generated at the Consensus Conference were discussed, emphasizing the rapid pace of recent scientific advancement and the need for ongoing empirical reevaluation and modification of the Group's proposal.

KW - β-Amyloid pathology

KW - Alzheimer's disease

KW - Diagnosis

KW - Neurofibrillary pathology

KW - Neuropathology

UR - http://www.scopus.com/inward/record.url?scp=0030713295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030713295&partnerID=8YFLogxK

U2 - 10.1016/S0197-4580(97)00068-7

DO - 10.1016/S0197-4580(97)00068-7

M3 - Article

C2 - 9330984

AN - SCOPUS:0030713295

VL - 18

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 4 SUPPL.

ER -